Ischemia-induced norepinephrine release, but not norepinephrine-derived free radicals, contributes to myocardial ischemia-reperfusion injury

Circulation Journal

Volumn 69, Issue 5, 2005, Pages 590-595

  Nonomura, Makoto ^a   Nozawa, Takashi ^a   Matsuki, Akira ^a   Nakadate, Teruo ^a   Igarashi, Norio ^a   Kato, Bun Ichi ^a   Fujii, Nozomu ^a   Igawa, Akihiko ^a   Asanoi, Hidetsugu ^a   Kondo, Takashi ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

blocker; Electron paramagnetic resonance; Rat; Sympathetic denervation

Indexed keywords

5,5 DIMETHYL 1 PYRROLINE 1 OXIDE; ATENOLOL; FREE RADICAL; NORADRENALIN; NORADRENALIN DERIVATIVE; PHENOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; DIALYSATE; ELECTRON SPIN RESONANCE; HEART DENERVATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; INTERSTITIAL FLUID; LEFT CORONARY ARTERY; MALE; MICRODIALYSIS; NONHUMAN; RAT; REPERFUSION INJURY; SPIN TRAPPING; SYMPATHETIC NERVE;

ANIMALS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NOREPINEPHRINE; RATS; RATS, WISTAR;

EID: 21144481912     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.590     Document Type: Article

References (46)

1. Waldenström AP, Hjalmarson AC, Tornell L. A possible role of noradrenaline in the development of myocardial infarction. Am Heart J 1978; 95: 43-51.
2. Hara A, Abiko Y. Role of the sympathetic nervous system in the ischemic and re-perfused heart. EXS 1996; 76: 285-297.
3. Rona G. Cathecholamine cardiotoxicity. J Mol Cell Cardiol 1985; 17: 291-306.
4. Kawabata M, Kubo I, Suzuki K, Terai T, Iwama T, Isobe M. 'Tako-Tsubo cardiomyopathy' associated with syndrome malin: Reversible left ventricular dysfunction. Circ J 2003; 67: 745-749.
5. Schömig A. Catecholamines in myocardial ischemia: Systemic and cardiac release. Circulation 1990; 82(Suppl II): II-13-II-22.
6. Ambrosio G, Tritto I. Reperfusion injury: Experimental evidence and clinical implications. Am Heart J 1999; 138: S69-S75.
7. Park JL, Lucchesi BR. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 1999; 68: 1905-1912.
8. Williams FM. Neutrophils and myocardial reperfusion injury. Pharmacol Ther 1996; 72: 1-12.
9. Lucchesi, BR. Myocardial ischemia, reperfusion and free radical injury. Am J Cardiol 1990; 65: 141-231.
10. Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, Yamamoto T, et al. Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J 2003; 67: 781-787.
11. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol 1981; 60: 1390-1397.
12. Obata T, Hosokawa H, Yamanaka Y. In vivo monitoring of norepinephrine and ·OH generation on myocardial ischemic injury by dialysis technique. Am J Physiol 1994; 35: H903-H908.
13. Obata T, Yamanaka Y. Cardiac microdialysis of salicylic acid ·OH generation on nonenzymatic oxidation by norepinephrine in rat heart. Biochem Pharmacol 1997; 53: 1375-1378.
14. Igawa A, Nozawa T, Yoshida N, Fujii N, Inoue M, Tazawa S, et al. Heterogeneous cardiac sympathetic innervation in heart failure after myocardial infarction of rats. Am J Physiol 2000; 278: H1134-H1141.
15. Mori H, Pisarri TE, Aldea GS, Husseini WK, Dae MW, Stevens MB, et al. Usefulness and limitations of regional cardiac sympathectomy by phenol. Am J Physiol 1989; 257: H1523-H1533.
16. Desprès G, Veissier I, Boissy A. Effect of autonomic blockers on heart period variability in calves: Evaluation of the sympatho-vagal balance. Physiol Res 2002; 51: 347-353.
17. Nozawa T, Igawa A, Yoshida N, Maeda M, Inoue M, Yamamura Y, et al. Dual-tracer assessment of coupling between cardiac sympathetic neuronal function and downregulation of β-receptors during development of hypertensive heart failure of rats. Circulation 1998; 97: 2359-2367.
18. Yamazaki T, Akiyama T, Shindo T. Routine high-performance liquid chromatographic determination of myocardial interstitial norepinephrine. J Chromatogr B Biomed Appl 1995; 670: 328-331.
19. Honda H, Zhao Q, Kondo T. Effects of dissolved gases and an echo contrast agent on apoptosis induced by ultrasound and its mechanism via the mitochondria-caspase pathway. Ultrasound Med Biol 2002; 28: 673-682.
20. Buettner GR. Spin trapping: ESR parameters of spin adducts. Free Radic Biol Med 1987; 3: 259-303.
21. Jones CE, Devous MD Sr, Thomas JX Jr, DuPont E. The effect of chronic cardiac denervation on infarct size following acute coronary occlusion. Am Heart J 1978; 95: 738-746.
22. Jones CE, Beck LY, DuPont E, Barnes GE. Effects of coronary ligation of the chronically sympathectomized dog ventricle. Am J Physiol 1978; 235: H429-H434.
23. Barber MJ, Thomas JX Jr, Jones SB, Randall WC. Effect of sympathetic nerve stimulation and cardiac denervation on MBF during LAD occlusion. Am J Physiol 1982; 243: H566-H574.
24. Matsuki T, Cohen MV, Holt G, Ayling J, Hearse DJ, Downey JM. Chronic whole body sympathectomy fails to protect ischemic rabbit heart. Am J Physiol 1989; 256: H1322-H1327.
25. Lavallee M, Amano J, Vatner SF, Manders WT, Randall WC, Thomas JX Jr. Adverse effects of chronic cardiac denervation in conscious dogs with myocardial ischemia. Circ Res 1985; 57: 383-392.
26. Elson JJ, Ten Eick RE, Singer DH. Autonomic nervous system and cellular injury from circumflex ligation in dogs. Am J Physiol 1981; 240: H738-H745.
27. Jones CE, Scheel KW. Reduced coronary collateral resistance after chronic ventricular sympathectomy. Am J Physiol 1980; 238: H196-H201.
28. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 1987; 21: 737-746.
29. Maisel AS, Motulsky HJ, Ziegler MG, Insel PA. Ischemia- and agonist-induced changes in α- and β-adrenergic receptor traffic in guinea pig hearts. Am J Physiol 1987; 253: H1159-H1166.
30. Strasser RH, Krimmer J, Braun-Dullaeus R, Marquetant R, Kübler W. Dual sensitization of the adrenergic system in early myocardial ischemia: Independent regulation of the β-adrenergic receptors and the adenylyl cyclase. J Mol Cell Cardiol 1990; 22: 1405-1423.
31. Gotzsche O. Decreased myocardial calcium uptake after isoproterenol in streptozotocin-induced diabetic rats. Lab Invest 1983; 48: 156-161.
32. Lubbe WH, Podzuweit T, Opie LH. Potential arrythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: Implications for prophylactic effects of beta-blockers in myocardial infarction and proarrythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol 1992; 19: 1622-1633.
33. Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, et al. Cardioprotective effects of carvedilol, a novel β-adrenoceptor antagonist with vasodilating properties, in anaesthetized minipigs: Comparison with propranolol. Cardiovasc Res 1992; 26: 518-525.
34. Burmeister WE, Reynolds RD, Lee RJ. Limitation of myocardial infarct size by atenolol, nadolol and propranolol in dogs. Eur J Pharmacol 1981; 75: 7-10.
35. Josephson RA, Silverman HS, Lakatta EG, Stern MD, Zweier JL. Study of the mechanism of hydrogen peroxide and hydroxyl free radical-induced cellular injury and calcium overload in cardiac myocytes. J Biol Chem 1991; 266: 2354-2361.
36. Kuzuya T, Hoshida S, Kim Y, Nishida M, Fuji H, Kitabatake A, et al. Detection of oxygen-derived free radical generation in the canine postischemic heart during late phase of reperfusion. Circ Res 1990; 66: 1160-1165.
37. Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchhesi BR. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984; 54: 277-285.
38. Ambrosio G, Becker LC, Hutchins GM, Weisman HF, Weisfeldt ML. Reduction in experimental infarct size by recombinant human superoxide dismutase: Insights into the pathophysiology of reperfusion injury. Circulation 1986; 74: 1424-1433.
39. Becker LB, Vanden Hoek TL, Shao Z, Li C, Shumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol 1999; 277: H2240-H2246.
40. Miki T, Choen MV, Downey JM. Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits. Basic Res Cardiol 1999; 94: 180-187.
41. Richard VJ, Murry CE, Jennings RB, Reimer KA. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 min of ischemia in dogs. Circulation 1988; 78: 473-480.
42. Takeo S, Liu JX, Tanonaka K, Nasa Y, Yabe K, Tanahashi H, et al. Reperfusion at reduced flow rates enhances postischemic contractile recovery of perfused heart. Am J Physiol 1995; 268: H2384-H2395.
43. Brunvand H, Kvitting PM, Rynning SE, Berge RK, Grong K. Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms. J Cardiovasc Pharmacol 1996; 28: 409-417.
44. + exchange structure, regulation, and its role in heart disease. Circ Res 1999; 85: 777-786.
45. Buettner GR, Oberley LW. Considerations in the spin trapping of superoxide and hydroxyl radical in aqueous systems using 5,5-dimethyl-1- pyrroline-1-oxide. Biochem Biophys Res Commun 1978; 83: 69-74.
46. Finkelstein E, Rosen GM, Rauckman EJ. Spin trapping of superoxide and hydroxyl radical: Practical aspects. Arch Biochem Biophys 1980; 200: 1-16.